Mayo Clinic Rochester: Cancer Care for International Patients

Mayo Clinic developed from a medical practice established in Rochester in the nineteenth century. It is now a not-for-profit organisation combining clinical care, education and research. Its Comprehensive Cancer Center has National Cancer Institute designation, reflecting an institutional cancer research programme rather than a guarantee of any individual treatment outcome.

The Rochester campus is a large, multispecialty medical setting rather than a stand-alone cancer hospital. Patients may receive consultations, investigations, outpatient treatments and hospital care in different facilities. The wider network includes major campuses in Phoenix, Arizona, and Jacksonville, Florida; services and trial openings are not identical across these locations.

Mayo Clinic is known for an integrated destination-medicine model in which specialists collaborate around a patient's medical needs. This can support coordinated, sometimes rapid diagnostic work-ups, particularly when pathology, imaging and surgical assessment must be considered together. Nevertheless, appointment availability, additional testing and medical complexity affect scheduling; a short or fixed-duration visit cannot be assumed.

Relevant programmes include liver and pancreatic cancers, where diagnosis and treatment planning often require input from gastrointestinal oncology, specialist surgeons, radiologists and other teams. Assessment may address whether an operation is feasible, whether treatment before surgery is appropriate, or whether systemic or local therapies offer a better approach. For liver cancer, underlying liver function is particularly important; transplant-related evaluation applies only to carefully selected situations.

Breast cancer care can include surgical planning, radiotherapy, hormone therapy, chemotherapy and treatments directed at tumour biomarkers. Blood cancer services cover conditions such as leukaemia, lymphoma and myeloma, with access to specialist assessment for transplantation or cellular therapy where appropriate. These are selected areas of focus, not an exhaustive list of cancers treated. The appropriate programme depends on the exact diagnosis, including pathological subtype and relevant molecular findings.

Surgery is available for many solid tumours, with the proposed procedure determined by disease extent and the patient's fitness. A multidisciplinary review may recommend surgery first, treatment before an operation, or a non-surgical approach. Patients should ask about the anticipated hospital stay, recovery needs and whether complications could delay their return home.

Precision oncology uses tumour characteristics, including selected molecular biomarkers, to inform treatment. Testing may identify a targeted treatment, help assess suitability for immunotherapy or support trial screening. It does not always reveal an actionable result. Systemic treatments may also include chemotherapy, hormone therapy and other medicines according to established indications.

Radiation services include conventional approaches and proton beam therapy in Rochester. Protons can reduce radiation exposure to some surrounding tissues in selected circumstances, but they are not automatically preferable for every tumour. Carbon-ion therapy is a separate technology: patients should not interpret references to Mayo Clinic's particle-therapy developments as confirmation of a routinely available carbon-ion service in Rochester. Site, operational status and access need direct verification.

CAR-T cell therapy is used for selected blood cancers, subject to the diagnosis, treatment history and clinical criteria. It involves specialist preparation and monitoring for potentially serious adverse effects. Supportive care, rehabilitation, symptom management and palliative care may accompany anticancer treatment at any stage.

The cancer centre conducts trials involving new medicines, treatment combinations, cellular therapies, radiation approaches and other cancer-related interventions. The supplied estimate of around 700 active oncology trials should be treated as indicative, not as a verified current total of studies recruiting in Rochester. Counts change and may include studies across multiple campuses, cancer types and recruitment categories.

International patients can ask for trial screening when requesting an appointment or during specialist assessment. Eligibility commonly depends on pathology, stage, biomarkers, previous treatments, organ function and general health. Residence abroad does not establish eligibility or guarantee access. The study team must confirm recruitment status, available places, consent requirements and whether prolonged local attendance is necessary. Patients should also clarify which research procedures are funded and which routine medical, travel and accommodation costs remain their responsibility.

Before travelling, request an assessment through Mayo Clinic's international appointment services and submit the records requested by the relevant department. Explain whether the aim is a second opinion, a diagnostic review, definitive treatment or trial consideration. Ask which appointments can be coordinated, which tests may need repeating and whether any assessment can occur remotely before travel.

Obtain written guidance on financial arrangements, expected phases of care and likely requirements for remaining near the hospital. Some therapies involve repeated visits or urgent access to specialist care. Plan for a caregiver if needed, and agree how prescriptions, treatment summaries and monitoring will transfer to your home oncology team. Avoid non-refundable travel plans until the appointment and medical travel requirements are clear.

Contact details below come from the hospital's own published international patient information.

Location: Rochester, United States

Email: intl.mayo@mayo.edu

Phone: +1 507 284 2511

Website: https://www.mayoclinic.org

Languages supported: English, Spanish, Arabic

Remote second opinion: Available

Always confirm current contact details on the hospital's own website before sending medical records, and never send documents to an address you have not verified.